BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/5/2017 12:48:27 AM | Browse: 1316 | Download: 1984
 |
Received |
|
2017-08-19 01:27 |
|
Peer-Review Started |
|
2017-08-19 06:47 |
|
To Make the First Decision |
|
2017-08-30 00:06 |
|
Return for Revision |
|
2017-09-04 06:14 |
|
Revised |
|
2017-09-18 04:11 |
|
Second Decision |
|
2017-09-25 06:03 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2017-09-28 18:03 |
|
Articles in Press |
|
2017-09-28 18:03 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2017-10-23 07:43 |
|
Publish the Manuscript Online |
|
2017-11-05 00:48 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Athanasios Kostas, Spyros I Siakavellas, Charalambos Kosmidis, Anna Takou, Joanna Nikou, Georgios Maropoulos, John Vlachogiannakos, George V Papatheodoridis, Ioannis Papaconstantinou and Giorgos Bamias |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Giorgos Bamias, MD, PhD, Associate Professor, Doctor, Doctor, Academic Department of Gastroenterology, University of Athens Medical School, Laiko Genreral Hospital, 17 Agiou Thoma Street, Athens 11527, Greece. gbamias@gmail.com |
| Key Words |
Fecal calprotectin; Biomarker; Inflammatory bowel disease; Mucosal healing; Clinical outcome; Relapse; Ulcerative colitis; Crohn’s disease |
| Core Tip |
Fecal calprotectin (FC) is a novel biomarker aiming to facilitate the assessment of inflammatory bowel disease (IBD) activity as its expression is driven by the presence of intestinal inflammation. Our present retrospective study provides evidence that FC measurement during clinical remission may be helpful in identifying early those cases with a higher risk of recurrence. Moreover, lower FC values seem to correlate with endoscopic quiescence of the disease. Thus, FC monitoring may be effective in recognizing distinct subgroups of IBD patients offering the opportunity to the clinician to tailor their management accordingly in order to achieve optimal disease control. |
| Publish Date |
2017-11-05 00:48 |
| Citation |
Kostas A, Siakavellas SI, Kosmidis C, Takou A, Nikou J, Maropoulos G, Vlachogiannakos J, Papatheodoridis GV, Papaconstantinou I, Bamias G. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease. World J Gastroenterol 2017; 23(41): 7387-7396 |
| URL |
http://www.wjgnet.com/1007-9327/full/v23/i41/7387.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i41.7387 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
